Project Grant HT94252510781
Award Date
9/30/25
Completion Date
9/29/28
Dollars Obligated
$560K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44195, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded The Cleveland Clinic Foundation a $383,740 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 30, 2024, supports the research and development of a "Novel Graft-Localized Drug Delivery Platform for Attenuating Innate Inflammation and Optimizing Immunosuppression in Vascularized Composite Allotransplantation." This project aims to develop innovative medical...
The Defense Health Agency awarded The Cleveland Clinic Foundation, a non-profit academic medical center, a $893,768 Project Grant under the Military Medical Research and Development (CFDA 12.420) program. The two-year grant, effective from September 1, 2023 to August 31, 2025, supports the development of multimodal AI-based solutions to enhance renal cancer patient care. As a leader in medical research, education, and healthcare delivery, The Cleveland Clinic Foundation will leverage its...
The Cleveland Clinic Foundation will receive $942,000 under a three-year Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program administered by the agency under Catalog of Federal Domestic Assistance number 12.420. The funding will support research investigating the role of a novel inhibitory receptor complex in driving T cell dysfunction and therapeutic resistance to immunotherapies in lung cancer....
The Department of Defense's Defense Health Agency awarded a $1,280,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The grant, awarded on September 1, 2025, supports research investigating the biological mechanisms and therapeutic relevance of the SLC1A1 amino acid transporter in kidney cancer. The Cleveland Clinic Foundation, a renowned nonprofit academic medical center, will conduct this advanced biomedical research...
The U.S. Department of Defense's Defense Health Agency (DHA) awarded a $2,602,024 Project Grant to The Cleveland Clinic Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on September 30, 2024, will fund research on the "Role of Stress in the Degradation of Intestinal IgA and Intestinal Health" over a 4-year period ending on September 29, 2028. As a prominent academic medical center, The Cleveland Clinic Foundation...
The Defense Health Agency awarded a $5,339,958 Project Grant to the Beckman Research Institute of the City of Hope under the Military Medical Research and Development (CFDA 12.420) program. The grant supports the development of a digital health intervention for self-management and telemonitoring in chimeric antigen receptor (CAR)-T cell therapy. This 4-year research project, running from June 2025 to June 2029, aims to advance medical solutions for the battlefield and transform healthcare for...
The Department of Defense's Defense Health Agency has awarded The Cleveland Clinic Foundation a $780,357 project grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the novel nuclear localization of the complement regulator CD55 and its potential to disrupt ovarian cancer progression. The award period runs from May 1, 2025 to April 30, 2029. This research project aims to investigate a new mechanism for treating ovarian cancer by exploring how...
This Project Grant award of $1,200,000 was provided by the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation. The grant supports advanced biomedical research aimed at developing therapeutic strategies to disrupt the CX26-FAK-NANOG complex in order to attenuate cancer stem cell self-renewal and progression of triple-negative breast cancer. The performance period for this grant is from May 1, 2025 to April 30, 2028. The...
The Defense Health Agency awarded a $640,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Cleveland Clinic Foundation, a non-profit academic medical center, to conduct research focused on "Evolutionary Experimentation Highlights Novel Therapeutic Vulnerabilities in Endometrial Cancer." The award duration is from September 1, 2024 to August 31, 2026. The Cleveland Clinic Foundation, which has extensive experience as both a prime...
The Defense Health Agency awarded a $1,023,225 Project Grant under the Military Medical Research and Development program (CFDA# 12.420) to The Cleveland Clinic Foundation. The grant funds research to investigate the therapeutic relevance of targeting the anti-apoptotic Bcl-xL protein in kidney cancer. A sub-award to Harvard T.H. Chan School of Public Health will perform BH3 profiling to compare apoptotic responses in renal cell carcinomas under varied conditions, including treatment with BH3...